Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma

There is no useful biomarker to evaluate treatment response and early relapse in head and neck squamous cell carcinoma (HNSCC). Circulating tumor DNA (ctDNA) is a promising biomarker for detecting minimal residual diseases and monitoring treatment effect. We investigated whether individualized ctDNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kogo, Ryunosuke, Manako, Tomomi, Iwaya, Takeshi, Nishizuka, Satoshi, Hiraki, Hayato, Sasaki, Yasushi, Idogawa, Masashi, Tokino, Takashi, Koide, Ayaka, Komune, Noritaka, Yasumatsu, Ryuji, Nakagawa, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636504/
https://www.ncbi.nlm.nih.gov/pubmed/35352507
http://dx.doi.org/10.1002/cam4.4726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636504/
https://www.ncbi.nlm.nih.gov/pubmed/35352507
http://dx.doi.org/10.1002/cam4.4726

Ejemplares similares